{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:29:35Z","timestamp":1791289775716,"version":"4.3.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1681\/asn.2012060571","type":"journal-article","created":{"date-parts":[[2012,11,26]],"date-time":"2012-11-26T22:20:33Z","timestamp":1353968433000},"page":"43-52","source":"Crossref","is-referenced-by-count":73,"title":["Loss of Properdin Exacerbates C3 Glomerulopathy Resulting from Factor H Deficiency"],"prefix":"10.1681","volume":"24","author":[{"given":"Marieta M.","family":"Ruseva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Lesher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm J.","family":"Schwaeble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssif M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Botto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordula M.","family":"Stover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew Caleb","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20230301","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrneph.2010.85","article-title":"C3 glomerulopathy: A new classification.","volume":"6","author":"Fakhouri","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"R2-11-20230301","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.molimm.2011.04.005","article-title":"Dense deposit disease.","volume":"48","author":"Smith","year":"2011","journal-title":"Mol Immunol"},{"key":"R3-11-20230301","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03574.x","article-title":"Translational mini-review series on complement factor H: Renal diseases associated with complement factor H: Novel insights from humans and animals.","volume":"151","author":"Pickering","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"R4-11-20230301","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat Genet"},{"key":"R5-11-20230301","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI117751","article-title":"Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.","volume":"95","author":"H\u00f8g\u00e5sen","year":"1995","journal-title":"J Clin Invest"},{"key":"R6-11-20230301","first-page":"608","article-title":"Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.","volume":"118","author":"Rose","year":"2008","journal-title":"J Clin Invest"},{"key":"R7-11-20230301","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-immunol-030409-101250","article-title":"Properdin: Emerging roles of a pattern-recognition molecule.","volume":"28","author":"Kemper","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"R8-11-20230301","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJM198807073190106","article-title":"Dysfunctional properdin in a Dutch family with meningococcal disease.","volume":"319","author":"Sj\u00f6holm","year":"1988","journal-title":"N Engl J Med"},{"key":"R9-11-20230301","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/00365548909035695","article-title":"Another Swedish family with complete properdin deficiency: Association with fulminant meningococcal disease in one male family member.","volume":"21","author":"S\u00f6derstr\u00f6m","year":"1989","journal-title":"Scand J Infect Dis"},{"key":"R10-11-20230301","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2249.1999.01056.x","article-title":"Properdin deficiency in a large Swiss family: Identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n).","volume":"118","author":"Sp\u00e4th","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"R11-11-20230301","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.4049\/jimmunol.180.5.3313","article-title":"Properdin plays a protective role in polymicrobial septic peritonitis.","volume":"180","author":"Stover","year":"2008","journal-title":"J Immunol"},{"key":"R12-11-20230301","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.0601094103","article-title":"Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice.","volume":"103","author":"Pickering","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-11-20230301","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2010050451","article-title":"The development of atypical hemolytic uremic syndrome depends on complement C5.","volume":"22","author":"de Jorge","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R14-11-20230301","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.molimm.2009.03.030","article-title":"Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase.","volume":"46","author":"Paix\u00e3o-Cavalcante","year":"2009","journal-title":"Mol Immunol"},{"key":"R15-11-20230301","doi-asserted-by":"crossref","first-page":"F1397","DOI":"10.1152\/ajprenal.90313.2008","article-title":"Complement activation by tubular cells is mediated by properdin binding.","volume":"295","author":"Gaarkeuken","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"R16-11-20230301","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ki.2010.132","article-title":"Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice.","volume":"78","author":"Fakhouri","year":"2010","journal-title":"Kidney Int"},{"key":"R17-11-20230301","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1172\/JCI41782","article-title":"Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury.","volume":"120","author":"Kimura","year":"2010","journal-title":"J Clin Invest"},{"key":"R18-11-20230301","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood-2007-05-089821","article-title":"Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement.","volume":"111","author":"Kimura","year":"2008","journal-title":"Blood"},{"key":"R19-11-20230301","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1074\/jbc.M508928200","article-title":"The role of properdin in the assembly of the alternative pathway C3 convertases of complement.","volume":"281","author":"Hourcade","year":"2006","journal-title":"J Biol Chem"},{"key":"R20-11-20230301","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.4049\/jimmunol.179.4.2600","article-title":"Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly.","volume":"179","author":"Spitzer","year":"2007","journal-title":"J Immunol"},{"key":"R21-11-20230301","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4049\/jimmunol.0903598","article-title":"An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.","volume":"185","author":"Agarwal","year":"2010","journal-title":"J Immunol"},{"key":"R22-11-20230301","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/bj2520047","article-title":"Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.","volume":"252","author":"Farries","year":"1988","journal-title":"Biochem J"},{"key":"R23-11-20230301","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1681\/ASN.2012060570","article-title":"Lethal murine C3 glomerulonephritis resembling human dense deposit disease caused by combined fH C-terminal mutation and properdin deficiency.","volume":"24","author":"Lesher","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R24-11-20230301","first-page":"73","article-title":"Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.","volume":"65","author":"Mollnes","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"R25-11-20230301","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0090-1229(89)90141-4","article-title":"A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.","volume":"50","author":"Clardy","year":"1989","journal-title":"Clin Immunol Immunopathol"},{"key":"R26-11-20230301","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0090-1229(90)90144-F","article-title":"Two types of C3 nephritic factor: Properdin-dependent C3NeF and properdin-independent C3NeF.","volume":"56","author":"Tanuma","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"R27-11-20230301","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0272-6386(12)81018-3","article-title":"Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III.","volume":"16","author":"Varade","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"R28-11-20230301","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1242\/dmm.008052","article-title":"Regulating complement in the kidney: Insights from CFHR5 nephropathy.","volume":"4","author":"Gale","year":"2011","journal-title":"Dis Model Mech"},{"key":"R29-11-20230301","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.4049\/jimmunol.166.11.6820","article-title":"Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice.","volume":"166","author":"Robson","year":"2001","journal-title":"J Immunol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201301000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:22:20Z","timestamp":1786130540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201301000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2012060571","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}